Herpes zoster vaccine awareness and acceptance among adults in Saudi Arabia: a survey-based cross-sectional study [PDF]
Tropical Diseases, Travel Medicine and Vaccines, 2023 Background Herpes zoster (shingles) is caused by reactivation of the varicella-zoster virus. Despite the recommended herpes zoster vaccine for individuals aged ≥ 50 years, its uptake remains low in Saudi Arabia.
Sarah AlMuammar +5 more
doaj +3 more sources
Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations. [PDF]
PLoS OneImportance Herpes zoster infection is common in immunocompromised individuals. Recently, the Advisory Committee on Immunization Practices recommended immunizing with the recombinant zoster vaccine (RZV). Objective To evaluate the efficacy, immunogenicity
Marra F, Yip M, Cragg JJ, Vadlamudi NK.
europepmc +3 more sources
Unraveling Herpes Zoster Vaccine Hesitancy, Acceptance, and Its Predictors: Insights From a Scoping Review [PDF]
Public Health ReviewsObjectivesHerpes zoster vaccination is critical in preventing herpes zoster virus infection and its associated consequences. Despite its relevance, global herpes zoster immunisation coverage remains alarmingly low.
Xiaolong Wang +7 more
doaj +3 more sources
Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine [PDF]
Case Reports in Ophthalmology, 2022 We present a case of herpes zoster keratitis reactivation shortly following the Shingrix vaccine. In our patient, reactivation of herpes zoster keratitis occurred a few weeks following the herpes zoster subunit (HZ/su) vaccine.
Tracy J. Lu, Christopher N. Ta
doaj +2 more sources
Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination [PDF]
Open Forum Infectious Diseases, 2022 Abstract Background The 2-dose recombinant zoster vaccine (RZV) series is recommended for prevention of herpes zoster (HZ) in adults aged ≥50 years, but data are limited on the impact of concomitant administration with other vaccines on subsequent HZ risk.
Katia J Bruxvoort +8 more
openaire +3 more sources
Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis. [PDF]
Front Immunol, 2022 Objective To investigate the efficacy, effectiveness and safety of recombinant zoster vaccine (RZV) and zoster vaccine live (ZVL) in immunocompetent and immunocompromised subjects.
Xia Y, Zhang X, Zhang L, Fu C.
europepmc +2 more sources
Awareness and vaccination willingness of middle-aged and elderly individuals in Southwest China toward to herpes zoster vaccine [PDF]
Human Vaccines & ImmunotherapeuticsThe incidence of herpes zoster is increasing in China’s aging society, and vaccination is the most effective preventive measure. However, vaccine hesitancy is a major obstacle. A survey was conducted among individuals aged 50 and above in Southwest China
Lingli Hou +9 more
doaj +2 more sources
Herpes Zoster Vaccine Live and Risk of Stroke Among Medicare Beneficiaries: A Population-Based Cohort Study. [PDF]
Stroke, 2021 Supplemental Digital Content is available in the text. Background and Purpose: Herpes zoster (HZ) is associated with increased risk of stroke, and zoster vaccine live (ZVL, Zostavax) reduces the risk of HZ.
Yang Q, Chang A, Tong X, Merritt R.
europepmc +2 more sources
Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients. [PDF]
Am J Transplant, 2021 Lung transplant recipients are at high risk for herpes zoster and preventive measures are a significant unmet need. We investigated the safety and immunogenicity of two doses of a recombinant zoster vaccine (RZV) in lung transplant recipients (≥50 years).
Hirzel C +10 more
europepmc +2 more sources
Bibliometric analysis and visualization mapping of herpes zoster vaccine publications from 1999 to 2024 [PDF]
Frontiers in MedicineBackgroundHerpes Zoster (HZ) is a viral skin disease caused by reactivation of latent Varicella Zoster Virus (VZV) in human ganglia, presenting with unilateral neuropathic pain and vesicular rash.
Wenli Gao +5 more
doaj +2 more sources